|
1
|
Liu SZ, Wang B, Zhang F, Chen Q, Yu L,
Cheng LP, Sun XB and Duan GC: Incidence, survival and prevalence of
esophageal and gastric cancer in linzhou city from 2003 to 2009.
Asian Pac J Cancer Prev. 14:6031–6034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwarz Re and Smith DD: Clinical impact
of lymphadenectomy extent in resectable gastric cancer of advanced
stage. Ann Surg Oncol. 14:317–328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu W, Yang Q, Liu B and Zhu Z: Serum
proteomics for gastric cancer. Clin Chim Acta. 431:179–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Oliveira R, Deschoemaeker S, Henze AT,
Debackere K, Finisguerra V, Takeda Y, Roncal C, Dettori D, Tack E,
Jönsson Y, et al: Gene-targeting of Phd2 improves tumor response to
chemotherapy and prevents side-toxicity. Cancer Cell. 22:263–277.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wani WA, Saleem K and Haque A: Platinum
compounds: A hope for future cancer chemotherapy. Anticancer Agents
Med Chem. 13:296–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakamoto J, Matsui T and Kodera Y:
Paclitaxel chemotherapy for the treatment of gastric cancer.
Gastric Cancer. 12:69–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao MR, Li Q, Liu ZL, Liu HH, Wang W, Liao
XL, Pan YL and Jiang JW: Harmine induces apoptosis in HepG2 cells
via mitochondrial signaling pathway. Hepatobiliary Pancreat Dis
Int. 10:599–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liao X, Che X, Zhao W, Zhang D, Bi T and
Wang G: The β-adrenoceptor antagonist, propranolol, induces human
gastric cancer cell apoptosis and cell cycle arrest via inhibiting
nuclear factor κB signaling. Oncol Rep. 24:1669–1676.
2010.PubMed/NCBI
|
|
9
|
Abe A and Yamada H: Harmol induces
apoptosis by caspase-8 activation independently of Fas/Fas ligand
interaction in human lung carcinoma H596 cells. Anticancer Drugs.
20:373–381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai F, Chen Y, Song Y, Huang L, Zhai D,
Dong Y, Lai L, Zhang T, Li D, Pang X, et al: A natural small
molecule harmine inhibits angiogenesis and suppresses tumour growth
through activation of p53 in endothelial cells. PLoS One.
7:e521622012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun WH, Sun YL, Fang RN, Shao Y, Xu HC,
Xue QP, Ding GX and Cheng YL: Expression of cyclooxygenase-2 and
matrix metalloproteinase-9 in gastric carcinoma and its correlation
with angiogenesis. Jpn J Clin Oncol. 35:707–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chan MW, Wong CY, Cheng AS, Chan VY, Chan
KK, To KF, Chan FK, Sung JJ and Leung WK: Targeted inhibition of
COX-2 expression by RNA interference suppresses tumor growth and
potentiates chemosensitivity to cisplatin in human gastric cancer
cells. Oncol Re. 18:1557–1562. 2007.
|
|
13
|
Sun WH, Zhu F, Chen GS, Su H, Luo C, Zhao
QS, Zhang Y, Shao Y, Sun J, Zhou SM, et al: Blockade of
cholecystokinin-2 receptor and cyclooxygenase-2 synergistically
induces cell apoptosis, and inhibits the proliferation of human
gastric cancer cells in vitro. Cancer Lett. 263:302–311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Sun K, Ding J, Xu H, Zhu L, Zhang
K, Li X and Sun W: Harmine induces apoptosis and inhibits tumor
cell proliferation, migration and invasion through down-regulation
of cyclooxygenase-2 expression in gastric cancer. Phytomedicine.
15:348–355. 2014. View Article : Google Scholar
|
|
15
|
He XP, Shao Y, Li XL, Xu W, Chen GS, Sun
HH, Xu HC, Xu X, Tang D, Zheng XF, et al: Downregulation of miR-101
in gastric cancer correlates with cyclooxygenase-2 overexpression
and tumor growth. FEBS J. 279:4201–4212. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Neugut AI, Hayek M and Howe G:
Epidemiology of gastric cancer. Semin Oncol. 23:281–291.
1996.PubMed/NCBI
|
|
17
|
Tuan TF, Tsai ML, Yeh KC, Huang HC, Chung
CT, Huang CL, Han CH, Chen CP, Wang MH, Shen CC, et al: Intravenous
paclitaxel against metastasis of human gastric tumors of diffuse
type. Cancer Chemother Pharmacol. 66:773–783. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Papadaki C, Mavroudis D, Trypaki M,
Koutsopoulos A, Stathopoulos E, Hatzidaki D, Tsakalaki E,
Georgoulias V and Souglakos J: Tumoral expression of TXR1 and TSP1
predicts overall survival of patients with lung adenocarcinoma
treated with first-line docetaxel-gemcitabine regimen. Clin Cancer
Res. 15:3827–3833. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Williams GT and Smith CA: Molecular
regulation of apoptosis: Genetic controls on cell death. Cell.
74:777–779. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun WH, Chen GS, Ou XL, Yang Y, Luo C,
Zhang Y, Shao Y, Xu HC, Xiao B, Xue YP, et al: Inhibition of COX-2
and activation of peroxisome proliferators activated receptor γ
synergistically inhibits proliferation and induces apoptosis of
human pancreatic carcinoma cells. Cancer Lett. 275:247–255. 2013.
View Article : Google Scholar
|
|
21
|
Tsujii M and DuBois RN: Alterations in
cellular adhesion and apoptosis in epithelial cells overexpression
prostaglandin endoperoxide synthase-2. Cell. 83:493–501. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sawaoka H, Tsuji S, Tsujii M, Gunawan ES,
Sasaki Y, Kawano S and Hori M: Cyclooxygenase inhibitors suppress
angiogenesis and reduce tumor growth in vivo. Lab Invest.
79:1469–1477. 1999.PubMed/NCBI
|
